Menu
Recruiting NCT07267364

Pelvic Floor Muscle Training and Dynamic Neuromuscular Stabilization Exercises in Pediatric Patients

No phase Interventional Urology Pediatric Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: PFMT.
Who it may be relevant to
Registry conditions: Urology, Pediatric Disorder. Basic parameters: 5 years — 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effects of Adding Dynamic Neuromuscular Stabilization to Pelvic Floor Muscle Training on Voiding Dysfunction in Children: A Randomized Controlled Trial

Overview

Dysfunctional voiding (DY) is one of the most common conditions in children. Various treatments are available. Participants will be randomly assigned to either PFMT (Group I) or PFMT+DNS (Group II). PFMT is the gold standard and routinely administered in hospitals for children diagnosed with dysfunctional voiding who are referred by a urologist. The PFMT group serves as the control group, and treatment will be scheduled for a total of 10 weeks, three days a week. During PFMT, children receive instruction about the pelvic floor using video visuals and increase awareness of their pelvic floor muscles. They are then instructed on how to contract and relax their muscles to control urination. DNS training is an exercise model that begins with spinal stabilization and addresses muscle synergies. Patients included in the study will be evaluated twice, at the beginning and at the end of the treatment: Voiding Disorders Symptom Score (VODS), Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0), Pediatric Incontinence Questionnaire (PIN-Q), Bladder Bowel Dysfunction Scale (BDS), Bristol gaita scale, and Children's Body Image Scale.

Interventions

  • Behavioral PFMT
    During PFMT, children are taught about the pelvic floor using video visuals and their awareness of the pelvic floor muscles is increased. They are then instructed on how to contract and relax their muscles to control urination. DNS exercises, on the other hand, is an exercise model that begins with spinal stabilization and focuses on muscle synergies. Participants in the study will be assessed twice: at the beginning and end of treatment, using the Voiding Disorders Symptom Score (VDSS), Pediatr

Primary outcome measures

  • Voiding Disorders Symptom Scoring (VDSS) [Time frame: 10 week]
  • Bladder and Bowel Dysfunction Scale (BBDS) [Time frame: 10 week]
Secondary outcome measures (6)
  • Pediatric Quality of Life Questionnaire (PEDSQL) [Time frame: 10 week]
  • Children's Body Image Scale [Time frame: 10 week]
  • Depression Scale for Children [Time frame: 10 week]
  • Pediatric Incontinence Questionnaire (PIN-Q) [Time frame: 10 week]
  • Pelvic Floor Muscle strength and endurance [Time frame: 10 week]
  • Bristol gaita scale [Time frame: 10 week]

Eligibility criteria

Inclusion criteria

  • Having been diagnosed with voiding dysfunction according to ICCS diagnostic criteria in a urology outpatient clinic,
  • Being 5-18 years old,
  • The child and their parent/guardian agree to participate in the study voluntarily and provide signed consent.

Exclusion criteria

  • Organic pathologies such as urethral obstruction, ectopic ureter, spinal dysraphism, and diabetes
  • Diagnosis of VUR or neurogenic bladder
  • Cognitive and mental impairment
  • Having spina bifida
  • Being under 5 years of age
  • Receiving treatment such as PTC training or electrical stimulation

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 2 centers
  • Necmettin Erbakan University — Konya
  • Hanife Dogan — Konya

Identifiers

NCT: NCT07267364 · 23743.R1

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗